3.24

5.19% 0.16

After Hours: 3.28 0.04 +1.23%

Amylyx Pharmaceuticals Inc (AMLX)

Overview News Price History Option Chain Financials Discussions Forecast

Amylyx Pharmaceuticals Inc stock is traded at $3.24, with a volume of 1.49M. It is up +5.19% in the last 24 hours and up +45.95% over the past month. Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Previous Close:

$3.08

Open:

$3.05

24h Volume:

1.49M

Relative Volume:

0.96

Market Cap:

$209.69M

Revenue:

$380.79M

Net Income/Loss:

$49.27M

P/E Ratio:

-2.6129

EPS:

-1.24

Net Cash Flow:

$10.68M

1W Performance:

+11.34%

1M Performance:

+45.95%

6M Performance:

+14.08%

1Y Performance:

-82.30%

1-Day Range:

$3.05

$3.27

1-Week Range:

$2.87

$3.28

52-Week Range:

$1.575

$19.95

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Name

Amylyx Pharmaceuticals Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

617-683-0917

Address

43 THORNDIKE STREET, CAMBRIDGE

Employee

384

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

AMLX's Discussions on Twitter

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-24	Initiated	Robert W. Baird	Outperform
Dec-12-23	Initiated	Deutsche Bank	Buy
Jul-24-23	Upgrade	Goldman	Neutral → Buy
Mar-31-23	Initiated	Mizuho	Buy
Jan-05-23	Initiated	BofA Securities	Buy
May-25-22	Initiated	Citigroup	Buy
Apr-01-22	Downgrade	Goldman	Buy → Neutral

View All

Amylyx Pharmaceuticals Inc Stock (AMLX) Latest News

08:28 AM

Amyotrophic Lateral Sclerosis Treatment Market is Booming with - openPR

08:28 AM

Sep 29, 2024

Almitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Sep 29, 2024

Sep 26, 2024

XTX Topco Ltd Purchases New Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Sep 26, 2024

Sep 24, 2024

Ratio Analysis: Unpacking America Movil S.A.B.DE C.V. ADR (AMX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 24, 2024

Alpha Metallurgical Resources (NYSE:AMR) Shares Up 8.1% - MarketBeat

Sep 24, 2024

A year in review: Amylyx Pharmaceuticals Inc (AMLX)’s performance in the last year - US Post News

Sep 24, 2024

Sep 23, 2024

Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily

Sep 23, 2024

A Guide To The Risks Of Investing In Amylyx Pharmaceuticals Inc (AMLX) - Knox Daily

Sep 23, 2024

Get in on Aldeyra Therapeutics Inc’s (ALDX) buy-in window today! - SETE News

Sep 23, 2024

Sep 22, 2024

Acadian Asset Management LLC Purchases Shares of 7,699 Amcor plc (NYSE:AMCR) - Defense World

Sep 22, 2024

Sep 19, 2024

Meiji Yasuda Life Insurance Co Boosts Holdings in Amcor plc (NYSE:AMCR) - Defense World

Sep 19, 2024

Sep 18, 2024

AMLX’s Stock Journey: What Investors Need to Know About Amylyx Pharmaceuticals Inc’s Performance - The InvestChronicle

Sep 18, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock Catapults 37% Though Its Price And Business Still Lag The Industry - Simply Wall St

Sep 18, 2024

Sep 17, 2024

Taking a Closer Look At Amarin Corp ADR (AMRN) Following Its Recent Trade - Knox Daily

Sep 17, 2024